BiVACOR
PrivateLast Round
Grant
Feb 20, 2024
Total Funding Raised
$39.58M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BiVACOR operates in Healthcare & Life Sciences and is based in Huntington Beach, California. Its latest recorded funding round was a Grant round in February 2024.
BiVACOR is a medical device company developing a total artificial heart to provide a long-term solution for patients with end-stage biventricular heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BiVACOR Comparables
Compare BiVACOR with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carmat | 85% | |
| Picard Medical, Inc. | 83% | |
| Neocor Therapeutics | 82% |
For institutional investors. Book with your work email.
BiVACOR Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 20, 2024 | ||||
| VC Round | Mar 29, 2023 | ||||
| Series B | May 19, 2021 | ||||
| Grant | May 19, 2021 | ||||
| Series A | May 17, 2018 | ||||
Grant | Oct 25, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BiVACOR Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OneVentures | Series B, Series A, VC Round |
| NIH RADx | Grant |
| Queensland Government | Grant |
| Monash University | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Cormorant Asset Management | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 15, 2026
Grew 18% QoQ, from 68 to 80 employees.
- May 7, 2025
Grew 16% QoQ, from 45 to 52 employees.
For institutional investors. Book with your work email.
BiVACOR Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BiVACOR's valuation, stock price, and market status.
Is BiVACOR a public or private company?
BiVACOR is a private company.
What is the current stock price of BiVACOR?
BiVACOR is a private company, so its shares have no public market price. Caplight tracks BiVACOR's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BiVACOR worth (valuation)?
Valuation information for BiVACOR is not publicly available.
Can I buy BiVACOR stock?
BiVACOR shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BiVACOR's last funding round?
BiVACOR's most recent funding round was Grant on February 20, 2024.
Who are the main investors in BiVACOR?
Key investors in BiVACOR include OneVentures, Cormorant Asset Management.
Will BiVACOR IPO soon?
No public IPO plans have been announced for BiVACOR.
How can I track BiVACOR secondary market activity?
Caplight tracks bids, offers, and trades in BiVACOR's shares on secondary markets.